Tyrosine hydroxylase (TyrH) is a pterin-dependent enzyme that catalyzes the hydroxylation of tyrosine to form dihydroxyphenylalanine. The oxidation state of the active site iron atom plays a central role in the regulation of the enzyme. The kinetics of reduction of ferric TyrH by several reductants were determined by anaerobic stopped-flow spectroscopy. Anaerobic rapid freeze-quench EPR confirmed that the change in the near-UV absorbance of TyrH upon adding reductant corresponded to iron reduction. Tetrahydrobiopterin reduces wild-type TyrH following a simple second-order mechanism with a rate constant of 2.8 ± 0.1 mM −1 s −1 . 6-Methyltetrahydropterin reduces the ferric enzyme with a second-order rate constant of 6.1 ± 0.1 mM −1 s −1 and exhibits saturation kinetics. No EPR signal for a radical intermediate was detected. Ascorbate, glutathione, and 1,4-benzoquinone all reduce ferric TyrH, but much more slowly than tetrahydrobiopterin, suggesting that the pterin is a physiological reductant. E332A TyrH, which has an elevated K m for tetrahydropterin in the catalytic reaction, is reduced by tetrahydropterins with the same kinetic parameters as those of the wild-type enzyme, suggesting that BH 4 does not bind in the catalytic conformation during the reduction. Oxidation of ferrous TyrH by molecular oxygen can be described as a single-step second-order reaction, with a rate constant of 210 mM −1 s −1 . S40E TyrH, which mimics the phosphorylated state of the enzyme, has oxidation and reduction kinetics similar to those of the wild-type enzyme, suggesting that phosphorylation does not directly regulate the interconversion of the ferric and ferrous forms.Tyrosine hydroxylase (TyrH) 1 is a pterin-dependent monooxygenase that catalyzes the hydroxylation of tyrosine to form dihydroxyphenylalanine (DOPA) using a non-heme iron atom in the active site to activate molecular oxygen (1). Formation of DOPA is the first and rate-limiting step in the biosynthesis of the catecholamine neurotransmitters dopamine, epinephrine, and norepinephrine. Because of the important physiological role played by TyrH, its activity is regulated at the posttranslational level by phosphorylation of serine residues and by feedback inhibition by catecholamines. The redox state of the iron plays a central role in this regulation, as shown in Scheme 1 (2,3). For catalysis, the active site iron must be ferrous (4); during catalysis it is oxidized to higher levels but returns to the ferrous form by the end of the catalytic cycle (5). However, in a side reaction independent of catalysis, oxygen can oxidize the ferrous iron to the inactive ferric form (2); the iron must then be reduced back to the ferrous † This work was funded in part by NIH Grants R01 GM47291 (to P.F.F.), T32 GM08523 (to P.A.F.), and R01 GM39451 (to S.W.R.).